Prenatal exposure to lead, δ-aminolevulinic acid, and schizophrenia: Further evidence

Environmental Health Perspectives

Volumn 116, Issue 11, 2008, Pages 1586-1590

  Opler, Mark G A ^a   Buka, Stephen L ^b   Groeger, Justina ^c   McKeague, Ian ^c   Wei, Catherine ^c   Factor Litvak, Pam ^c   Bresnahan, Michaeline ^c,d   Graziano, Joseph ^c   Goldstein, Jill M ^e   Seidman, Larry J ^f   Brown, Alan S ^a,d   Susser, Ezra S ^a,c,d  

^a Columbia University ^*  (United States)

^b BROWN UNIVERSITY   (United States)

^c New York State Psychiatric Institute ^*  (United States)

^d NEW YORK STATE PSYCHIATRIC INSTITUTE   (United States)

^e HARVARD MEDICAL SCHOOL   (United States)

^f MASSACHUSETTS MENTAL HEALTH CENTER   (United States)

Author keywords

Developmental; Lead; Pb; Prenatal; Prospective; Psychosis; Schiz ophrenia; aminolevulinic acid

Indexed keywords

AMINOLEVULINIC ACID; LEAD; BIOLOGICAL MARKER;

ADOLESCENT; ADULT; AMINO ACID BLOOD LEVEL; ARTICLE; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DELIVERY; FEMALE; HIGH RISK POPULATION; HUMAN; INFANT; LEAD BLOOD LEVEL; LEAD POISONING; MAJOR CLINICAL STUDY; MALE; MATERNAL AGE; PATHOGENESIS; PRENATAL EXPOSURE; PRIORITY JOURNAL; RISK ASSESSMENT; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; UNITED STATES; BLOOD; CHEMICALLY INDUCED DISORDER; PREGNANCY;

AMINOLEVULINIC ACID; BIOLOGICAL MARKERS; FEMALE; HUMANS; LEAD; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; SCHIZOPHRENIA;

EID: 58849100414     PISSN: 00916765     EISSN: 15529924     Source Type: Journal    
DOI: 10.1289/ehp.10464     Document Type: Article

References (30)

1. Buka SL, Tsuang MT, Torrey EF, Klebanoff MA, Wagner RL, Yolken RH. 2001. Maternal cytokine levels during pregnancy and adult psychosis. Brain Behav Immun 4:411-420.
2. Centers for Disease Control and Prevention. 1992. Blood lead levels among children in high-risk areas - California, 1987-1990. MMWR Morb Mortal Wkly Rep 41(17):291-294.
3. American Psychiatric Association. 2000. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Arlington, VA:American Psychiatric Publishing.
4. Dietrich KN, Ris MD, Succop PA, Berger OG, Bornschein RL. 2001. Early exposure to lead and juvenile delinquency. Neurotoxicol Teratol 23:511-518.
5. Endo Y, Okayama A, Endo G, Horiguchi S, Nakazono N. 1993. Improvement of urinary delta-aminolevulinic acid determination by HPLC-fluorometry using pre-column derivatization. Sangyo Igaku 35:126-127.
6. Guilarte T. 2004. Prenatal lead exposure and schizophrenia: a plausible neurobiologic connection. Environ Health Perspect 112:A724.
7. Gulson BL, Mizon KJ, Palmer JM, Korsch MJ, Taylor AJ, Mahaffey KR. 2004. Blood lead changes during pregnancy and postpartum with calcium supplementation. Environ Health Perspect 112:1499-1507.
8. Imre G. 2007. The preclinical properties of a novel group II metabotropic glutamate receptor agonist LY379268. CNS Drug Rev 13(4):444-464.
9. Krabbendam L, van Os J. 2005. Schizophrenia and urbanicity: a major environmental influence - conditional on genetic risk. Schizophr Bull 31(4):795-799.
10. Lanphear BP, Hornung R, Khoury J, Yolton K, Baghurst P, Bellinger DC, et al. 2005. Low-level environmental lead exposure and children's intellectual function: an international pooled analysis. Environ Health Perspect 113:894-899.
11. Marcelis M, Navarro-Mateu F, Murray R, Selten JP, Van Os J. 1998. Urbanization and psychosis: a study of 1942-1978 birth cohorts in the Netherlands. Psychol Med 28(4):871-879.
12. McGrath J, Eyles D, Mowry B, Yolken R, Buka S. 2003. Low maternal vitamin D as a risk factor for schizophrenia: a pilot study using banked sera. Schizophr Res 63:73-78.
13. McGrath JJ, Murray RM. 2003. Risk factors in schizophrenia: from conception to birth. In: Schizophrenia (Hirsch SR, Weinberger DR, eds). Oxford, UK:Blackwell, 232-250.
14. Meyer PA, Pivetz T, Dignam TA, Homa DM, Schoonover J, Brody D. 2003. Surveillance for elevated blood lead levels among children - United States, 1997-2001. MMWR Surveill Summ 52(10):1-21.
15. 2+: association with deficits of LTP and spatial learning. Neurotoxicology 22:635-643.
16. Oishi H, Nomiyama H, Nomiyama K, Tomokuni K. 1996. Fluorometric HPLC determination of aminolevulinic acid (ALA). J Anal Toxicol 20:106-110.
17. Opler MG, Brown AS, Graziano J, Desai M, Zheng W, Schaefer C, et al. 2004. Prenatal lead exposure, delta-aminolevulinic acid, and schizophrenia. Environ Health Perspect 112:548-552.
18. Pedersen CB, Mortensen PB. 2006. Urbanization and traffic related exposures as risk factors for schizophrenia. BMC Psychiatry 6(1):2; doi: 10.1186/1471-244X-6-2 [Online 19 January 2006].
19. Pedersen CB, Raaschou-Nielsen O, Hertel O, Mortensen PB. 2004. Air pollution from traffic and schizophrenia risk. Schizophr Res 66(1):83-85.
20. Perrin M, Brown A, Malaspina D. 2007. Aberrant epigenetic regulation could explain the relationship of paternal age to schizophrenia. Schizophr Bull 33(6):1270-1273.
21. Rabe-Hesketh S, Skrondal A, Pickles A. 2004. GLLAMM Manual. Technical Report 160. University of California-Berkeley Division of Biostatistics Working Paper Series. Available: http://www.bepress.com/ucbbiostat/ paper160/ [accessed 30 December 2006].
22. Rabinowitz M, Needleman H, Burley M, Finch H, Rees J. 1984. Lead in umbilical blood, indoor air, tap water, and gasoline in Boston. Arch Environ Health 39(4):299-301.
23. Sargent JD, Bailey A, Simon P, Blake M, Dalton MA. 1997. Census tract analysis of lead exposure in Rhode Island children. Environ Res 74(2):159-168.
24. Secchi GC, Erba L, Cambiaghi G. 1974. Delta-aminolevulinic acid dehydrase activity of erythrocytes and liver tissue in man. Arch Environ Health 28:130-132.
25. St. Clair D, Xu M, Wang P, Yu Y, Fang Y, Zhang F, et al. 2005. Rates of adult schizophrenia following prenatal exposure to the Chinese famine of 1959-1961. JAMA 294(5):557-562.
26. Strauss R, Dietz W. 1999. Low maternal weight gain in the second or third trimester increases the risk for intrauterine growth retardation. J Nutr 129(5):988-993.
27. Susser E, Neugebauer R, Hoek HW, Brown AS, Lin S, Labovitz D, et al. 1996. Schizophrenia after prenatal famine. Further evidence. Arch Gen Psychiatry 53(1):25-31.
28. Susser ES, Schaefer CA, Brown AS, Begg MD, Wyatt RJ. 2000. The design of the Prenatal Determinants of Schizophrenia study. Schizophr Bull 26:257-273.
29. Thomas HV, Milmore BK, Heidbreder GA, Kogan BA. 1967. Blood lead of persons living near freeways. Arch Environ Health 15:695-702.
30. Tomokuni K, Ichiba M, Fujishiro K. 1993. Interrelation between urinary delta-aminolvulinic acid (ALA), serum ALA, and blood lead in workers exposed to lead. Ind Health 31:51-57.